Literature DB >> 21237268

The inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substances.

Binghai Zhao1, Qingquan Lian, Yanhui Chu, Dianne O Hardy, Xiao-Kun Li, Ren-Shan Ge.   

Abstract

11β-Hydroxysteroid dehydrogenase 2 (11β-HSD2) regulates active glucocorticoid access to glucocorticoid and mineralocorticoid receptors by metabolizing it to an inactive form. Perfluoroalkylated substances (PFASs) are man-made polyfluorinated compounds that are widely used and persistent in the environment. We tested the inhibitory potencies of four PFASs including perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorohexanesulfonate (PFHxS) and perfluorobutane sulfonate (PFBS) on human and rat 11β-HSD2. PFOS was a potent inhibitor of both human (IC(50)=48 nM) and rat (IC(50)=293 nM) 11β-HSD2 activities. The potencies for the inhibition of human and rat 11β-HSD2 activities were PFOS>PFOA>PFHxS>PFBS. PFASs showed competitive inhibition of both human and rat 11β-HSD2 activities. This observation indicates that PFOS is a potent endocrine disruptor for glucocorticoid metabolism. Article from the Special issue on Targeted Inhibitors.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21237268     DOI: 10.1016/j.jsbmb.2010.12.017

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  12 in total

1.  Associations of serum perfluoroalkyl substance and vitamin D biomarker concentrations in NHANES, 2003-2010.

Authors:  Taylor M Etzel; Joseph M Braun; Jessie P Buckley
Journal:  Int J Hyg Environ Health       Date:  2018-11-28       Impact factor: 5.840

Review 2.  Adipocytes under assault: environmental disruption of adipose physiology.

Authors:  Shane M Regnier; Robert M Sargis
Journal:  Biochim Biophys Acta       Date:  2013-06-02

3.  Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.

Authors:  Nan Li; Yun Liu; George D Papandonatos; Antonia M Calafat; Charles B Eaton; Karl T Kelsey; Kim M Cecil; Heidi J Kalkwarf; Kimberly Yolton; Bruce P Lanphear; Aimin Chen; Joseph M Braun
Journal:  Environ Int       Date:  2021-01-06       Impact factor: 9.621

4.  Chronic hypokalaemia in a hypertensive patient.

Authors:  Saban Elitok; Friedrich C Luft
Journal:  Clin Kidney J       Date:  2012-04-18

5.  Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood.

Authors:  Ana María Mora; Emily Oken; Sheryl L Rifas-Shiman; Thomas F Webster; Matthew W Gillman; Antonia M Calafat; Xiaoyun Ye; Sharon K Sagiv
Journal:  Environ Health Perspect       Date:  2016-06-28       Impact factor: 9.031

6.  Prenatal Exposures to Perfluoroalkyl Acids and Associations with Markers of Adiposity and Plasma Lipids in Infancy: An Odense Child Cohort Study.

Authors:  Richard Christian Jensen; Marianne S Andersen; Pia Veldt Larsen; Dorte Glintborg; Christine Dalgård; Clara Amalie Gade Timmermann; Flemming Nielsen; Maria Boysen Sandberg; Helle Raun Andersen; Henrik Thybo Christesen; Philippe Grandjean; Tina Kold Jensen
Journal:  Environ Health Perspect       Date:  2020-07-06       Impact factor: 9.031

7.  Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis.

Authors:  Tanya L Alderete; Ran Jin; Douglas I Walker; Damaskini Valvi; Zhanghua Chen; Dean P Jones; Cheng Peng; Frank D Gilliland; Kiros Berhane; David V Conti; Michael I Goran; Lida Chatzi
Journal:  Environ Int       Date:  2019-03-04       Impact factor: 9.621

8.  Phthalate-associated hypertension in premature infants: a prospective mechanistic cohort study.

Authors:  Randall Jenkins; Shane Tackitt; Ladawna Gievers; Sandra Iragorri; Kylie Sage; Tonya Cornwall; Declan O'Riordan; Jennifer Merchant; David Rozansky
Journal:  Pediatr Nephrol       Date:  2019-04-26       Impact factor: 3.714

9.  Prenatal exposure to perfluoroalkyl substances and adipocytokines: the HOME Study.

Authors:  Catherine O Buck; Melissa N Eliot; Karl T Kelsey; Antonia M Calafat; Aimin Chen; Shelley Ehrlich; Bruce P Lanphear; Joseph M Braun
Journal:  Pediatr Res       Date:  2018-09-13       Impact factor: 3.756

10.  The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study.

Authors:  Houman Goudarzi; Atsuko Araki; Sachiko Itoh; Seiko Sasaki; Chihiro Miyashita; Takahiko Mitsui; Hiroyuki Nakazawa; Katsuya Nonomura; Reiko Kishi
Journal:  Environ Health Perspect       Date:  2016-05-24       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.